MONOPAR THERAPEUTICS INC (MNPR)

US61023L1089 - Common Stock

0.67  +0.02 (+3.08%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
8.83M10.54M9.13M6.51M4.32M
Research and Development
5.60M7.59M6.49M4.07M1.97M
Selling, General, and Administrative Expenses
3.23M2.95M2.63M2.44M2.36M
Operating Income
-8.83M-10.54M-9.13M-6.51M-4.32M
Interest Income/Expense
429.04K20.00K20.00K80.00K100.00K
Other Income/Expense
N/AN/A0.00120.00KN/A
Income Before Taxes
-8.40M-10.52M-9.10M-6.30M-4.22M
Net Income
-8.40M-10.52M-9.10M-6.30M-4.22M
 
Per Share Data
EPS Diluted Total Ops
-0.61-0.83-0.73-0.58-0.41
Non GAAP EPS
-0.61-0.83-0.74-0.59N/A
 
Statistics

All data in USD

Charts